Pipeline

Our Research

Gynecological Oncology

Platinum-resistant ovarian cancer (PROC)
CBP-1008 , CBP-1019

Genitourinary Oncology

Metastatic castration-resistant prostate cancer (mCRPC)
CBP-1018 , CBP-8088

Gastrointestinal Cancer

Pancreatic cancer
CBP-1019
Esophagus cancer
CBP-1019

Thoracic Malignancies

Triple-negative breast cancer (TNBC)
CBP-1008 , CBP-8088
Lung cancer (LC)
CBP-1019 , CBP-8088

Bone Metastases

CBP-1018
CBP-1203

Product

Indications

Target

Payload

Pre-clinical

IND enabling

Phase I

Phase II/III

NDA

CBP-1008

PROC
TNBC

FRα × TRPV6

Tubulin
Inhibitor

CBP-1018

mCRPC
Bone metastases

FRα × PSMA

Tubulin
Inhibitor

CBP-1019

PROC
LC
Pancreatic cancer
Esophagus cancer

FRα × TRPV6

Topoisomerase Inhibitor

CBP-1029

Solid cancer

EGFR × cMET

Topoisomerase Inhibitor

CBP-8088

mCRPC
TNBC

undisclosed

PROTAC

CBP-1039

Solid cancer

undisclosed

Topoisomerase Inhibitor

CBP-1203

Solid cancer

undisclosed

Radioactive Isotope

CBP-1602

Solid cancer

undisclosed

Photodynamic Therapies